A new study shows hospitals serving mainly minority patients are just as likely as other hospitals to offer standard surgical care for early-stage breast. The study was presented at  the virtual American College of Surgeons (ACS) Clinical Congress 2020.

The researchers assessed whether disparities exist in the application of these evidence-based guidelines depending on whether a hospital serves predominantly minorities. The researchers defined minority-serving hospitals (MSH) as those in the top 10 percent treating the largest proportion of Black and Hispanic patients.They included more than 21,000 breast cancer patients treated in 2015 and 2016 from a database comprised of more than 70 percent of newly diagnosed cancer cases in the U.S. The information comes from more than 1,500 cancer programs, all accredited by the ACS Commission on Cancer, and is the largest database of its kind, the researchers noted. The researchers then divided 7,167 patients into three groups by matching the cancer characteristics to the inclusion criteria for these clinical trials.

The results showed there was a similar uptake of the recommendation to omit axillary lymph node dissection (ALND) between MSH and non-MSH (74.6 percent versus 72.9 percent, respectively).

“There are a lot of health disparities in cancer: in access to care, treatment, and outcomes,” said senior study investigator T. Salewa Oseni, MD, FACS, assistant professor of surgery, Harvard Medical School, Boston via a press release. “In our study, we were pleasantly surprised there was no difference between the care that Black, Hispanic, and white women receive.”

“Minority-serving hospitals offer a strong level of evidence-based breast cancer care if accredited by the Commission on Cancer,” Dr. Oseni concluded. “However, they cannot generalize their study findings to hospitals lacking this accreditation.”

Credit: Original article published here.